Surmodics (SRDX) Set to Announce Quarterly Earnings on Wednesday

Surmodics (NASDAQ:SRDX) is set to issue its quarterly earnings data before the market opens on Wednesday, May 1st. Analysts expect the company to announce earnings of ($0.36) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Surmodics Stock Performance

Shares of SRDX opened at $26.92 on Wednesday. The company has a current ratio of 4.84, a quick ratio of 3.97 and a debt-to-equity ratio of 0.24. The firm’s fifty day simple moving average is $29.14 and its two-hundred day simple moving average is $31.79. Surmodics has a 12 month low of $16.79 and a 12 month high of $39.41. The stock has a market capitalization of $383.34 million, a P/E ratio of 70.84 and a beta of 1.01.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Needham & Company LLC restated a “buy” rating and set a $47.00 target price on shares of Surmodics in a research report on Wednesday, April 10th. StockNews.com lowered shares of Surmodics from a “strong-buy” rating to a “buy” rating in a research note on Wednesday.

About Surmodics

Surmodics, Inc, together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD).